Long-term tolerability of inhaled human insulin (Exubera®) in patients with poorly controlled type 2 diabetes (vol 61, pg 1614, 2007)

被引：0
|
作者：
Barnett, A. H.
Lange, P.
Dreyer, M.
Serdarevic-Pehar, M.
机构：
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2008年 / 62卷 / 01期
关键词：
D O I：
10.1111/j.1742-1241.2007.01664.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [31] LONG-TERM COST-EFFECTIVENESS ANALYSIS OF IDEGLIRA VERSUS IGLARLIXI FOR THE TREATMENT OF PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN IN THE ITALIAN SETTING
    Montagnoli, R.
    Lastoria, G.
    Parekh, W.
    Pohlmann, J.
    Hunt, B.
    VALUE IN HEALTH, 2018, 21 : S131 - S131
  • [32] Long-term cost-effectiveness analysis of a modern insulin in patients with poorly controlled type 2 diabetes in the german setting; Data from the predictive study
    Palmer, J. L.
    Goodall, G.
    Aagren, M.
    Nielsen, S.
    Kotchie, R.
    Valentine, W. J.
    VALUE IN HEALTH, 2007, 10 (06) : A264 - A264
  • [33] Inhaled human insulin treatment in patients with type 2 diabetes mellitus
    Cefalu, WT
    Skyler, JS
    Kourides, IA
    Landschulz, WH
    Balagtas, CC
    Cheng, SL
    Gelfand, RA
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (03) : 203 - 207
  • [34] A Recent Survey Confirms the Efficacy and the Safety of Implanted Insulin Pumps During Long-Term Use in Poorly Controlled Type 1 Diabetes Patients
    Schaepelynck, Pauline
    Renard, Eric
    Jeandidier, Nathalie
    Hanaire, Helene
    Fermon, Catherine
    Rudoni, Sabine
    Catargi, Bogdan
    Riveline, Jean-Pierre
    Guerci, Bruno
    Millot, Luc
    Martin, Jean-Francois
    Sola, Agnes
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (06) : 657 - 660
  • [35] Short-term intravenous insulin infusion and endothelial function in poorly controlled type 2 diabetes patients
    Saryusz-Wolska, M.
    Czupryniak, L.
    Pawlowski, M.
    Borkowska, A.
    Grzelak, P.
    Stefanczyk, L.
    Loba, J.
    DIABETOLOGIA, 2006, 49 : 695 - 696
  • [36] Long-term glycaemic control with pioglitazone in patients with type 2 diabetes (vol 58, pg 192, 2004)
    Campbell, IW
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (10) : 993 - 993
  • [37] Long-term evaluation of the cost-effectiveness of biphasic insulin aspart 30 versus insulin glargine in poorly controlled patients with type 2 diabetes receiving oral antidiabetic agents
    Cobden, D
    Palmer, A
    Nicklasson, L
    Roze, S
    Garber, A
    DIABETOLOGIA, 2005, 48 : A336 - A336
  • [38] Dual therapy with inhaled human insulin (Exubera®) as add-on to metformin (with stopping sulfonylurea) is better than triple therapy with rosiglitazone add-on to combination metformin and sulfonylurea in poorly controlled type 2 diabetes
    Rosenstock, Julio
    Gross, Jorge
    Eliaschewitz, Reddy
    Mitnick, Michael
    Lawrence, David
    Canovatchel, William
    Hollander, Priscilla
    DIABETES, 2008, 57 : A557 - A557
  • [39] Long-Term Intensive Insulin Therapy for Japanese Patients with Type 2 Diabetes Mellitus
    Umezono, Tomoya
    Toyoda, Masao
    Abe, Makiko
    Kobayashi, Keiko
    Kato, Mayuko
    Miyauchi, Masaaki
    Kobayashi, Takako
    Yamamoto, Naoyuki
    Kimura, Moritsugu
    Yagame, Mitsunori
    Suzuki, Daisuke
    INTERNAL MEDICINE, 2008, 47 (24) : 2109 - 2115
  • [40] Results of insulin antibody monitoring during phase II and phase III clinical studies of inhaled insulin (Exubera®) in patients with Type 1 or Type 2 diabetes
    Fineberg, SE
    Schatz, D
    Krasner, A
    DIABETOLOGIA, 2002, 45 : A17 - A18
12345